Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy

Retina

Volumn 30, Issue 10, 2010, Pages 1671-1677

  Lee, Byung Joo ^a   Gon Yu, Hyeong ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR DISEASE; DIABETIC RETINOPATHY; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INCIDENCE; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RECURRENT DISEASE; RETINA TEAR; RISK FACTOR; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ADULT; AGED; CONJUNCTIVA; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPOTENSION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SUTURE TECHNIQUES; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 78649345128     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181dcfb79     Document Type: Article

References (22)

1. Yorston D, Wickham L, Benson S, Bunce C, Sheard R, Charteris D. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy. Br J Oph-thalmol 2008;92:365-368.
2. Novak MA, Rice TA, Michels RG, Auer C. Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology 1984;91:1485-1489. (Pubitemid 15197020)
3. Tolentino FI, Cajita VN, Gancayco T, Skates S. Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy. Ophthalmology 1989;96:1495-1500.
4. Hershberger VS, Augsburger JJ, Hutchins RK, Raymond LA, Krug S. Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings. Ophthalmology 2004;111:1215-1221.
5. Blankenship GW. Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy. Ophthalmology 1986;93:39-44.
6. Yeh PT, Yang CM, Yang CH, Huang JS. Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study. Ophthalmology 2005;112:2095-2102.
7. Yang CM, Yeh PT, Yang CH. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy. Ophthalmology 2007;114:710-715.
8. Romano MR, Gibran SK, Marticorena J, Wong D, Heimann H. Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage? Eye 2009;23: 1698-1701.
9. Faghihi H, Taheri A, Farahvash MS, Esfahani MR, Rajabi MT. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial. Retina 2008;28:1241-1246.
10. Fujii GY, De Juan E, Jr., Humayun MS, et al. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology 2002;109:1814-1820.
11. Kadonosono K, Yamakawa T, Uchio E, Yanagi Y, Tamaki Y, Araie M. Comparison of visual function after epiretinal membrane removal by 20-gauge and 25-gauge vitrectomy. Am J Ophthalmol 2006;142:513-515.
12. Shimada H, Nakashizuka H, Mori R, Mizutani Y. Expanded indications for 25-gauge transconjunctival vitrectomy. Jpn J Ophthalmol 2005;49:397-401.
13. Altan T, Acar N, Kapran Z, Unver YB, Ozdogan S. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment. Retina 2008;28:1201-1206.
14. Cusick M, SanGiovanni JP, Chew EY, et al. Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. Am J Ophthalmol 2005;139:1042-1050.
15. Brown GC, Tasman WS, Benson WE, McNamara JA, Eagle RC Jr. Reoperation following diabetic vitrectomy. Arch Ophthalmol 1992;110:506-510.
16. Soto-Pedre E, Hernaez-Ortega MC, Vazquez JA. Risk factors for postoperative hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmic Epidemiol 2005;12:335-341.
17. Bhende M, Agraharam SG, Gopal L, et al. Ultrasound biomicroscopy of sclerotomy sites after pars plana vitrectomy for diabetic vitreous hemorrhage. Ophthalmology 2000;107: 1729-1736.
18. Krieger AE. The pars plana incision: experimental studies, pathologic observations, and clinical experience. Trans Am Ophthalmol Soc 1991;89:549-621.
19. Acar N, Kapran Z, Unver YB, Altan T, Ozdogan S. Early postoperative hypotony after 25-gauge sutureless, vitrectomy with straight incisions. Retina 2008;28:545-552.
20. Hsu J, Chen E, Gupta O, Fineman MS, Garg SJ, Regillo CD. Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes. Retina 2008;28: 937-940.
21. Mason JO III, Colagross CT, Haleman T, et al. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy. Am J Ophthalmol 2005;140:231-235.
22. Schiff WM, Barile GR, Hwang JC, et al. Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes. Ophthalmology 2007;114:544-550.